Pseudomonas aeruginosa -- Staphylococcus aureus -- Drug Resistant Tuberculosis CHAPTER FIVE: COMPANY SNAPSHOTS --...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ABBOTT LABORATORIES
Abbott Laboratories is a diversified pharmaceuticals healthcare company headquartered in Abbot Part, Illinois. It operates in four segments: pharmaceutical products; diagnostic products; nutritional products; and vascular products. In 1985, Abbott develop dthe first HIV screen test. The company’s drug portfolio includes Humira, Synthroid, and Dupakote; and its most popular nutritional product is Ensure.
Abbott Laboratories is part of Business Exchange, suggested by
Maki Yamasaki.
This topic contains
894 news
and
191 blog
items.
Read updated news, blogs, and resources about Abbott Laboratories. Find user-submitted articles and reactions on Abbott Laboratories from
like-minded professionals.
News
Please add new articles to this topic
and opportunities in the industry. Companies Mentioned: F. Hoffmann-La Roche Ltd. Beckman Coulter, Inc.
of Advanced Medical Optics, Inc. ('Advanced Medical') (: Last: Delayed quote data Analyst Create alert Insider Discuss...
cents, or 4.8%, to $19.98. In the health care sector, deal news was in focus, as Abbott Laboratories (nyse: ABT - news...
of 2000 through 2015. The report profiles 39 companies including many key and niche players worldwide such as Abbott...
Miles White, who reshaped Abbott Laboratories over the past decade through big deals, is positioned for another...
A unit of Bayer AG has filed a patent-infringement lawsuit in a U.S. court against Abbott Laboratories relating to the...
free from infection,' FDA division chief Jesse Goodman said in a statement. Other companies offering HIV tests include...
WASHINGTON -(Dow Jones)- Federal regulators warned Abbott Laboratories (ABT) over an advertisement for the company's...
Luskin, MD, Sheldon Spector, MD, and William Storms, MD. This multi-sponsored activity is made possible by Sepracor,...
Abbott (NYSE: ABT) today announced the start of SPIRIT Small Vessel, a clinical trial evaluating a 2.
Abbott (NYSE: ABT | Quote | Chart | News | PowerRating) (Current Market Cap: US$81.13 Bil.) said that it has exercised...
Drug-maker Abbott Laboratories (ABT.N) will buy smaller firm Isis Pharmaceuticals Inc's (ISIS.O) unit, Ibis Biosciences...
Abbott Laboratories has forged a deal to buy a unit of Isis Pharmaceuticals for $175 million--on top of a $40 million...
mil The drug maker will buy Isis Pharmaceuticals' (ISIS) Ibis Biosciences unit in a deal worth $215 mil.
to treat the heart defect. It bought the U.S. rights to that competitor in January 2006 from Abbott Laboratories.
DOW JONES NEWSWIRES Abbott Laboratories (ABT) received approval from the Food and Drug Administration for...
money-saving tactic will be greater use of inexpensive generics through new incentives. We have 'strong buy'...
Extract not available.
Top Sources: Abbott Laboratories
- BusinessWeek
- MarketWatch
- thedeal.com
- Chicago Tribune
- Reuters
- CNN Money
- chicagobusiness.com
- TheStreet.com
- CNBC
- pharma-iq.com
account